Angiotensin II receptor blockers and insulin resistance


The growing concern about the increasing prevalence of the metabolic syndrome and type 2 diabetes mellitus has generated substantial interest in the metabolic effects of antihypertensive drugs.1,2 The metabolic syndrome is strongly associated with insulin resistance and consists of a constellation of factors such as hypertension and hyperlipidemia that… (More)
DOI: 10.1038/hr.2010.99